Alzheimer's disease

With Alzheimer's drugs in focus, Bristol Myers rejoins the hunt
BioPharma Dive
Thu, 06/24/21 - 12:35 pm
Bristol Myers Squibb
Prothena
Alzheimer's disease
PRX005
Warren, Cassidy want hearing on new Alzheimer's drug coverage
The Hill
Thu, 06/24/21 - 11:07 am
Senate
Biogen
Aduhelm
Medicare
Alzheimer's disease
Bill Cassidy
Elizabeth Warren
Eisai-Biogen Alzheimer’s drug gets FDA breakthrough designation
Pharmaceutical Business Review
Thu, 06/24/21 - 10:56 am
Eisai
Biogen
FDA
lecanemab
breakthrough status
Alzheimer's disease
FDA documents show how controversial Alzheimer's drug decision was reached
BioPharma Dive
Tue, 06/22/21 - 10:50 pm
Biogen
Aduhelm
FDA
Alzheimer's disease
Woodcock defends Biogen's new Alzheimer's drug, says it has more supportive data than many past accelerated approvals
Endpoints
Tue, 06/22/21 - 10:34 pm
FDA
Janet Woodcock
Biogen
Aduhelm
Alzheimer's disease
Biogen's new Alzheimer's drug serves as a rallying cry for drug pricing reforms
Endpoints
Tue, 06/22/21 - 11:14 am
EmployersRx
Biogen
Alzheimer's disease
drug pricing
Roche's Alzheimer's antibody lowers biomarkers in inherited form of disease, though impact on symptoms is unclear
Fierce Biotech
Mon, 06/21/21 - 11:08 am
Roche
gantenerumab
Alzheimer's disease
clinical trials
biomarkers
'This is not a shotgun approach to dementia': Hospital execs share how they're rolling out Aduhelm
Beckers Hospital Review
Fri, 06/18/21 - 10:09 am
Biogen
Aduhelm
hospitals
Alzheimer's disease
First patient receives controversial Biogen Alzheimer's drug
NASDAQ
Wed, 06/16/21 - 11:40 pm
Biogen
Aduhelm
Alzheimer's disease
Biogen's other Alzheimer's drug fails in late-stage trial
Bizjournals
Wed, 06/16/21 - 11:26 pm
Biogen
Alzheimer's disease
clinical trials
gosuranemab
Public Citizen demands removal of top FDA officials over Biogen Alzheimer's approval
Seeking Alpha
Wed, 06/16/21 - 11:58 am
Biogen
FDA
Public Citizen
Aduhelm
Alzheimer's disease
Janet Woodcock
VectorY raises $38M to develop Alzheimer's, ALS gene therapies
Fierce Biotech
Tue, 06/15/21 - 11:37 pm
VectorY Therapeutics
gene therapy
ALS
Alzheimer's disease
Despite controversy, Biogen's Aduhelm is already generating enthusiasm among doctors: survey
Fierce Pharma
Tue, 06/15/21 - 11:43 am
Biogen
Aduhelm
physicians
Alzheimer's disease
These 3 Words From the FDA Ensure the Biogen Drama Is Far From Over
Motley Fool
Tue, 06/15/21 - 10:39 am
FDA
Biogen
Aduhelm
accelerated approvals
Alzheimer's disease
‘I’m just winging it’: Faced with confusing data on the new Alzheimer’s drug, doctors scramble to advise their patients
Stat
Mon, 06/14/21 - 10:13 am
physicians
Biogen
Aduhelm
FDA
Alzheimer's disease
Eli Lilly, Roche's Alzheimer's prospects, including flops, boosted in light of FDA's Aduhelm approval: analysts
Fierce Biotech
Fri, 06/11/21 - 12:10 pm
Eli Lilly
Roche
Biogen
Alzheimer's disease
FDA
beta-amyloid plaque
80% of pharma workers think Aduhelm's approval was a mistake, survey says
Beckers Hospital Review
Thu, 06/10/21 - 11:50 pm
Biogen
Aduhelm
FDA
Alzheimer's disease
Third member of FDA expert committee resigns over controversial Alzheimer’s therapy decision
Stat
Thu, 06/10/21 - 11:48 pm
FDA
Alzheimer's disease
Biogen
Aduhelm
Senators lambast new Alzheimer’s drug’s price but give Janet Woodcock a free pass on the approval decision
Endpoints
Thu, 06/10/21 - 11:44 pm
Senate
Biogen
Alzheimer's disease
Aduhelm
Janet Woodcock
FDA
AdComm exodus: 2nd expert quits over FDA approval of Biogen's Aduhelm
Fierce Biotech
Thu, 06/10/21 - 11:07 am
FDA
Biogen
Alzheimer's disease
Aduhelm

Pages